Alkermes to Present at Goldman Sachs 38th Annual Global Healthcare Conference
June 08 2017 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that its Chief
Executive Officer, Richard Pops, will participate in a fireside
chat at the Goldman Sachs 38th Annual Global Healthcare Conference
on Thursday, June 15, 2017 at 8:40 a.m. PT (11:40 a.m. ET/4:40 p.m.
BST) from Rancho Palos Verdes, Calif. The audio portion of the
fireside chat may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170608005887/en/
Alkermes plcJennifer Zibuda, +1 781-609-6129Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024